Lifebridge 10000

Lifebridge 10000

Transforming metastatic cancer from a terminal prognosis to a manageable disease like diabetes

Security Type
Common Stock
Min Investment
Offering Date
August 24, 2021
Expected Close Date
April 29, 2022
Target Raise
Security Price

Company Description

The team at Lifebridge 10000 continues building its patent-pending LB10000 device, built from the ground up for late-stage cancer patients with metastatic disease in two or more locations on the body at once. Future patients treating metastatic cancer with Tumor Treating Fields (TTF) will not be left with the painful decision of what cancer to treat and which to let grow. 

Key Deal Facts

Our device can extend the proven benefits of Tumor Treating Fields (TTF) therapy to patients with metastatic cancer.
On any given day 500,000+ cancer patients could be helped by our therapy. Without it they will die.
Value creation! Tumor Treating Fields has experienced explosive growth up 736% since 2018 (Forbes).
We solve the limitations of the current therapy. 2 U.S. Patents 3rd pending. Pending in 36 counties.

Use of Proceeds

  • Operational & Personnel Expenses
  • New Patents, Legal, Software
  • Completion of IDE, ATTIF Systems for Animal Study and Human Pilot
  • Patient Pilot Trial Expenses

Management Team / Advisory Board Bios

Peter F Travers, CEO and Founder, Managing Member of LifeBridge
He has a BA in communication from UCF. His first company was a medical ed firm that sold materials he created. He designed a marketing program that sold the training products to 3,000 hospitals.

Lee Zehngebot M.D., Medical Advisor
Dr. Lee Zehngebot has served as the Director of Clinical Research, Florida Hospital Cancer Institute in Orlando since 2007 and has participated as Principal Investigator and Co-Investigator on numerous clinical studies. Medical advisor to the company.

Ken Watkins, Founding Member and Chief Technologist
Mr. Watkins has 40 years of experience in the electronic engineering field, including 17 with Northrop Grumman Corp. While at Northrup he was responsible for 30 electrical engineers.
Amount Raised : $164,028
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter